Author: Dr. Pawan Gupta

Dr. Pawan Gupta is a trusted Senior Surgical Oncologist, social activist, and author, engaged in creating awareness and changing the way cancer is perceived in society. He is a renowned transformational speaker on cancer chronic diseases and lifestyle specifically tobacco. Thousands have benefitted from his workshops, seminars, camps, and training programs. He has been featured in Buzz Creator and on many channels on TV. He is the Founder of ICanCaRe, an Innovative enterprise for Cancer Care and Rehabilitation. Working extensively in Tobacco Cessation data-driven protocol-based intervention through a network of Specialists and experts on ICanCaRe APP, Virtual Clinics, and ICanCaRe National Quitline. National Convenor for Tobacco Cessation courses for the first time in India introduced under Gujarat University His populist campaigns “WIN OVER CANCER”, “SAVE the Youth – Win over tobacco”, “Chota Daana”, “Catch them Early”, and “My Hygiene My Responsibility” has gained him wide accolades. In his mission to win over cancer, he has a unique methodological approach to quitting tobacco. The book WIN OVER TOBACCO – MADE EASY is a step-by-step guide for tobacco addicts to overcome their cravings. The Book had more than 10000 Downloads within 30 Days of being made available. He received the prestigious ICD International Award in 2007, Vivekananda Sister Margarette Award 2017 and Delhi NGO leadership Award 2017, AIECS award 2018, Asia Africa Leadership in Social Innovation 2019, MICC Innovation Award 2019, Rashtriya Prabasi Odia Paribar Award 2019. Professionally he has conducted more than 11000 cancer surgeries and was a pioneer in establishing and modernizing surgical oncology in some of the major hospitals in Delhi NCR. He did his graduation and post-graduation from SCB Medical College, Cuttack. He enhanced his surgical skills M.Ch and Fellowship in Surgical Oncology from Gujarat Cancer Research Institute (GCRI), Ahmedabad. He has held several positions during his career in various hospitals. Dr. Pawan has published 30 papers in National and International journals and is actively involved in several research projects. He is an active member of the Telemedicine Society of India, India Association of Surgical Oncology, Association of Surgeons of India, and Foundation for Head and Neck Oncology. He is seen as a mentor of strayed souls, and a soothing balm to those tormented by cancer.

“ICanCaRe: A Critical Response to the Increased Risk of Asthma Hospitalization in Children Exposed to Second-hand Smoke”

“ICanCaRe: A Critical Response to the Increased Risk of Asthma Hospitalization in Children Exposed to Second-hand Smoke”

A pivotal study published in the Annals of Allergy, Asthma & Immunology reveals a concerning correlation between second-hand smoke exposure and increased hospitalization risks in children with bronchial asthma, particularly following infections like respiratory syncytial virus (RSV).[1,2] This underscores the urgency of interventions like the ICanCaRe tobacco cessation program. (www.icancare.in)

Conducted by researchers from Kyushu University, Fukuoka, Japan, the study examined the impact of second-hand smoke on 2248 children who had a history of RSV infection and 444 children with a history of human metapneumovirus (hMPV) infection. Among these, 56 children had experienced both infections. The study, which sourced data from the Japan Health Insurance Association database (April 2004 to March 2017), reported that 38% of children with RSV infection, 40% with hMPV infection, and 39% with both infections were exposed to second-hand smoke.

The findings were alarming: hospitalization rates for asthma control were significantly higher in children exposed to second-hand smoke (4.5%) compared to their non-exposed counterparts (2.7%). Furthermore, the diagnosis of bronchial asthma occurred earlier in the exposed group, with a median age of 22 months, as opposed to 25 months in the unexposed group.

For children who developed hMPV infection at 12 months or older, those exposed to second-hand smoke were diagnosed with bronchial asthma at an average age of 33 months, compared to 47 months in non-exposed children. Notably, in children who had hMPV infection before 12 months, there were no hospitalizations in the second-hand smoke group.[2]

The study also highlighted those children with pre-existing bronchial asthma and RSV infection faced a greater risk of hospitalization if exposed to second-hand smoke. The odds ratio (OR) for hospital admission due to asthma exacerbation in these children was 1.69. [2]

The synergy between viral infections like RSV, hMPV, and second-hand smoke exposure in exacerbating bronchial asthma is a critical public health concern. This study not only points to the heightened risk of pediatric asthma but also to the urgent need for protective measures against second-hand smoke exposure.

The ICanCaRe digitalized tobacco cessation program (www.icancare.in) emerges as a beacon of hope in this scenario. By focusing on tobacco cessation and raising awareness about the dangers of second-hand smoke, ICanCaRe is positioned to play a pivotal role in mitigating the risk of pediatric asthma, especially in vulnerable children with a history of RSV or hMPV infections. With the #advicequittobacco campaign, we implore all doctors to ask and advice about tobacco use and quitting and refer them to the ICanCaRe centers for a 100% successful quit program. Call 011-43077695 or write to info@icancare.in and download the ICanCaRe tobacco Wellness APP (http://app.icancare.in)

Through programs like ICanCaRe, there is potential to reduce the onset and severity of pediatric asthma, providing a healthier future for our children as part of the prime campaign #SAVEtheYouth. The findings of this study serve as a powerful reminder of the critical importance of such interventions.

References:

1. Yoshizato R, et al. Secondhand smoking and pediatric asthma after respiratory syncytial virus or human metapneumovirus infection. Ann Allergy Asthma Immunol. 2023 Oct 18:S1081-1206(23)01342-X. doi: 10.1016/j.anai.2023.10.013.

2. Stong C. Available at: https://www.pulmonologyadvisor.com/home/topics/lung-infection/secondhand-smoke-rsv-and-pediatric-bronchial-asthma/. Dated Nov. 10, 2023. Accessed on Nov. 14, 2023.

#icancare #asthma #secondhandsmoking #icancareapp

#15th ICanCaRe Tutorial for Certified Tobacco Cessation Specialists

On November 20, 2023, the 15th tutorial for Certified Tobacco Cessation Specialists was held, marked by a productive collaboration between Dr. Mariya, Dr. Siddhi, Dr. Anshika, and the new addition to the coordinator team, Dr. Abhishek Bhadranna.

Agenda Highlights:

1. Case Discussion on PAAN Cessation: Dr. Anshika Pandey presented a compelling case of a paan (betel leaf) consumer and shared the successful guidance provided to help the individual quit this habit.

2. Integration of WHO Guidelines on Tobacco and Diabetes: Dr. Rakesh Gupta from SIPHER and Dr. Pawan Gupta led a discussion on the recent WHO guidelines concerning tobacco and its connection to diabetes. They highlighted how ICanCaRe has incorporated these guidelines into the ABCD model for comorbidity management.

3. Turning Tobacco Cessation into a Success Story: Participants engaged in a thoughtful dialogue on transforming tobacco cessation into a successful endeavor. The focus was on building confidence and establishing a strong identity in the field of tobacco cessation. Attendees were tasked with creating their professional identity, including designing visiting cards and flyers.

4. Special Pricing for Tobacco-Related Medications: Information regarding exclusive pricing for tobacco-related medications for CTCS in clinic settings was shared to facilitate more accessible treatment options.

5. Acknowledging ICanCaRe: Dr. Pawan Gupta emphasized the importance of CTCS acknowledging ICanCaRe in all their presentations, both online and offline, to strengthen the collective mission.

Members’ Feedback:

– Siddhi continued to express her appreciation for the ongoing opportunities for learning and professional growth.

– Abhishek expressed gratitude to all participants for their valuable contributions and highlighted the wealth of knowledge gained during the session.

– Rakesh commended the inclusion of comorbidity management into ICanCaRe cessation and emphasized the tutorial’s importance for anyone looking to excel in the field.

– Dr. Rajkumari underscored the tutorial’s role in enhancing learning and skill development.

– Kshipra expressed gratitude for the enriching learning experience.

ICanCaRe Academy Tutorial for Certified Tobacco Cessation Specialists (CTCS) is a monthly program held on the 15th of each month, from 9-10 PM. The program encourages CTCS to present complex cases on tobacco cessation for discussion and finding solutions to facilitate successful quitting. To submit cases or for further information, individuals can contact Dr. Mariya, Dr. Siddhi, Dr. Anshika, or Dr. Abhishek.

ICanCaRe Academy encourages active participation in these monthly sessions to gain profound insights into practical tobacco cessation through case discussions. Aspiring Certified Tobacco Cessation Specialists can explore the certification process at www.icancare.in/academy/ctcs

Stay connected with us on social media:

#icancareacademy #icancaretutorial #icancare #siddhi #pawangupta #CTCS #icancare #mariya #anshikapandey #abhishekbhadranna

Understanding the Link Between Smoking Cessation and Reduced Type 2 Diabetes Risk

In a groundbreaking collaboration, the World Health Organization (WHO), the International Diabetes Federation (IDF), and the University of Newcastle have released a policy brief emphasizing the significant health benefits of quitting smoking, particularly in relation to type 2 diabetes.

The Key Findings

– Reduced Risk of Type 2 Diabetes: The brief reveals that individuals who quit smoking can lower their risk of developing type 2 diabetes by an impressive 30-40%. This statistic highlights the profound impact that smoking cessation can have on one’s health, especially considering the prevalence and seriousness of type 2 diabetes.

– Impact on Blood Sugar Regulation: Smoking has been found to influence the body’s ability to regulate blood sugar levels. This dysregulation is a key factor in the development of type 2 diabetes, making smoking cessation a crucial step in mitigating this risk.

The joint policy brief by the WHO, IDF, and the University of Newcastle serves as a critical reminder of the power of lifestyle changes in preventing chronic diseases. For tobacco users, the decision to quit smoking can be a life-changing one, significantly reducing the risk of developing type 2 diabetes and improving overall health. This information is not only crucial for individuals but also for healthcare systems and policymakers, guiding them in creating effective strategies to combat the dual challenges of smoking and diabetes globally.

In light of the significant findings from the joint policy brief by the WHO, IDF, and the University of Newcastle, the relevance of the ICanCaRe Tobacco Cessation Program becomes increasingly important. This program plays a crucial role in facilitating the journey towards a smoke-free life, especially for those at risk of developing type 2 diabetes.

ICanCaRe Tobacco Cessation Program: A Beacon of Hope

1. Personalized Approach: The ICanCaRe program is designed to offer personalized support to individuals seeking to quit Tobacco. Understanding that each journey is unique, the program tailors its strategies to meet the specific needs and challenges of each participant. (www.app.icancare.in)

2. Comprehensive Support System: The program encompasses a range of support mechanisms, including counseling, behavioral therapy, and medical assistance in a protocol based approach provided by Certified Tobacco Cessation Specialists. This multi-faceted ABCD approach for tobacco cessation ensures that individuals have access to all necessary resources to 100% quit smoking or Chewing tobacco. The program is supported by

3. Educational Resources: ICanCaRe books and IEC materials also focus on educating participants about the health risks associated with smoking, including the increased risk of type 2 diabetes. By providing evidence-based information, the program empowers individuals to make informed decisions about their health.

4. Community and Peer Support through TOBACCO MARSHALs: Recognizing the importance of a supportive community, the program trains TOBACCO MARSHALS (www.icancare.in/academy/marshal) to create influence in society.

References and Further Reading

For those interested in delving deeper into the topic, the following references provide valuable insights:

  1. World Health Organization, International Diabetes Federation, and the University of Newcastle. “Policy Brief on Smoking and Type 2 Diabetes.” This brief offers a comprehensive overview of the research linking smoking cessation to a reduced risk of type 2 diabetes.
  2. ICanCaRe. “Tobacco Cessation Program Overview.” www.icancare.in
  3. American Diabetes Association. “The Impact of Smoking on Diabetes and Diabetes Management.” This article discusses the implications of smoking on diabetes management and the benefits of cessation.
  4. National Institute of Diabetes and Digestive and Kidney Diseases. “Smoking and Diabetes.” This resource offers a deeper understanding of how smoking affects diabetes risk and control.
  5. ICanCaRe. (2021). ABCD of Tobacco Cessation. https://www.icancare.org/abcd.html

Conclusion

The collaboration between the WHO, IDF, and the University of Newcastle, along with programs like ICanCaRe, highlights the critical intersection of smoking cessation and diabetes prevention. By leveraging these resources and programs, individuals can significantly reduce their risk of type 2 diabetes and improve their overall health, marking a substantial step forward in public health and personal well-being.

#icancare #diabetesandSmoking #smoking #quittobacco #icancareapp